bullish
Genetron (泛生子) Pre-IPO: Positive Development but Tracking Behind Burning Rock
341 Views15 Jun 2020 18:08
Genetron, a China-based precision oncology company, plans to raise up to USD 150 million to list in the US. In our previous note, we discussed that...
SUMMARY
(Sign Up to Access)Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
- Unlock all research summaries
- Follow top, independent analysts
- Receive personalised alerts and emails
- Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 4-minute read)
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
- ECM Weekly (20 June 2020) - Hygeia, Kangji, Genetron, JD.com, Archosaur, Pop Mart21 Jun 2020
- Genetron (泛生子) IPO Trading: Priced at Our Fair Value, yet There Could Be Upside19 Jun 2020
- Genetron (泛生子) IPO: Metrics Inferior to Burning Rock16 Jun 2020
- Genetron (泛生子) Pre-IPO: Positive Development but Tracking Behind Burning Rock15 Jun 2020
- Genetron (泛生子) Pre-IPO: Expertise to Be Proven Outside Brain Tumor02 Dec 2019
x